Insiders Trades
Unitedhealth Group Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 16 May 2025.
Unitedhealth Group Inc: what insiders have been doing
Unitedhealth Group Inc, classified in the Healthcare & Pharma sector, is a listed company based in Minnetonka, United States, founded in 1977. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 18 October 2026, brought 120 filings signed by 18 insiders.
All open-market trades in the period are sales: 1 sale worth €243k, by 1 insider, with no purchase on record. Conway Patrick Hugh filed the largest sale, €243k, on 27 April 2026, which represents 0.0001% of the company's market value.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 120 filings here. The full history, which starts in 2016, counts 8 purchases against 34 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 447.57 bn USD and net income at 12.06 bn USD; the dividend was 8.73 USD per share.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
753
Thresholds
n/a
Buy Volume
€30M
8 ops. · all time
Sell Volume
€104M
34 ops. · all time
Who traded when
BuySalePatrick Hugh Conway4 sales
Timothy Patrick Flynn2 buys
Charles D. Baker1 sale
Erin McSweeney1 sale
John F. Rex1 buy
John H. Noseworthy1 buy
+2 other insiders
Since the insiders bought
- +23.8%Entry US$315.89 · Close at T+365 US$391.13
- +23.8%Entry US$315.89 · Close at T+365 US$391.13
- +23.8%Entry US$315.89 · Close at T+365 US$391.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Unitedhealth Group Inc Buy (bullish), based on 25 analysts. Average price target: US$480.68.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,555 of 24,148 companies
45.3
score / 100
Value47
Quality43
FCF yld4.5%
Earn yld3.3%
EV/EBITDA19.0x
ROE16%
Gross mgn19%
Net mgn2.7%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$377.76
Analyst consensus
25 analystsBuy
US$380.00Target US$480.68(+27%)US$529.00
Income statement
RevenueUS$447.6B
Gross profitUS$82.9B19% margin
EBITDAUS$23.1B5% margin
Net incomeUS$12.1B3.1% margin
Valuation
PER (trailing)24.3x
PER (forward)16.6x
P/Book3.6x
Beta0.62
Balance sheet & cash
Market capUS$339.1B
Total debtUS$78.4B
Free Cash FlowUS$16.1B
Debt / Equity69%
Profitability & ownership
ROE14.2%
ROA4.9%
% insiders0.2%
% institutions89.6%
Last declaration on 5 October 2026
Declarations753 total
240 shares0Common StockSEC:0000731766-26-000253:0
257 shares0Common StockSEC:0000731766-26-000252:0
257 shares0Common StockSEC:0000731766-26-000250:0
240 shares0Common StockSEC:0000731766-26-000249:0
155 shares0Common StockSEC:0000731766-26-000248:0
103 shares0Common StockSEC:0000731766-26-000248:1
262 shares0Common StockSEC:0000731766-26-000247:0
291 shares0Common StockSEC:0000731766-26-000251:0
257 shares0Common StockSEC:0000731766-26-000246:0
10 shares0Common StockSEC:0000731766-26-000225:0
50 shares0Common StockSEC:0000731766-26-000228:0
15 shares0Common StockSEC:0000731766-26-000233:0
91.029 shares0Common StockSEC:0000731766-26-000224:0
106.233 shares0Common StockSEC:0000731766-26-000223:0
68 shares0Common StockSEC:0000731766-26-000232:0
16 shares0Common StockSEC:0000731766-26-000226:0
5 shares0Common StockSEC:0000731766-26-000230:0
57 shares0Common StockSEC:0000731766-26-000235:0
47 shares0Common StockSEC:0000731766-26-000227:0
53.225 shares0Common StockSEC:0000731766-26-000221:0
83.94 shares0Common StockSEC:0000731766-26-000222:0
46 shares0Common StockSEC:0000731766-26-000231:0
51.084 shares0Common StockSEC:0000731766-26-000234:0
66.975 shares0Common StockSEC:0000731766-26-000229:0
1,208.895 shares@ US$399.660.0001% mcap16.5% of flowCommon StockSEC:0000731766-26-000203:0
25 of 753 declarations
About Unitedhealth Group Inc
UnitedHealth Group Inc. (NYSE: UNH) is a United States-listed healthcare leader operating on the American market and one of the largest integrated health services companies in the world. Its business model is built around two core platforms: UnitedHealthcare, which provides health benefits and insurance coverage management, and Optum, which brings together care delivery, pharmacy services, data analytics, technology-enabled health services, and population-health capabilities. For investors, UNH stands out because it is not a pure insurer: it is a diversified healthcare platform that combines underwriting, clinical services, pharmacy-benefit management, and technology within one enterprise.
The company’s roots go back to 1977, with earlier origins linked to Charter Med Incorporated, founded in 1974 in Minnesota. Over time, UnitedHealth Group expanded through both organic growth and acquisitions to become a foundational player in the U.S. healthcare system. The group is historically associated with Minnesota, while its operating footprint is national and, through Optum and related service lines, extends beyond a purely domestic insurance franchise. In its most recent disclosures, UnitedHealth reported serving tens of millions of consumers through UnitedHealthcare and more than 100 million people across Optum’s businesses, underscoring the scale of its reach.
Read moreShow less
From a competitive standpoint, UnitedHealth Group benefits from size, diversification, and vertical integration. UnitedHealthcare sells employer-sponsored, individual, Medicare, and public-program coverage, while Optum provides a broad suite of services spanning care delivery, pharmacy benefit management, technology, and analytics. This structure gives the group multiple levers for growth and margin management, but it also increases exposure to reimbursement pressure, regulatory scrutiny, medical-cost inflation, and ongoing debates about claims handling and access to care. In other words, UNH combines defensive healthcare demand with meaningful operational complexity.
Recent developments matter for the investment case. The company reported strong 2024 results and then, in 2025, entered a period of operational reset, including leadership changes, a rebaselining of parts of Optum, and additional transparency actions. UnitedHealth also reported full-year 2025 results and issued its 2026 outlook, with consolidated 2025 revenue of $447.6 billion. Several executive changes were announced in spring 2025, signaling a broader strategic and governance adjustment as the company responded to a tougher operating backdrop.
For French, Belgian, and Swiss investors, UnitedHealth Group remains a flagship U.S. healthcare stock with a dominant market position, deep cash-generating capacity, and substantial strategic importance. At the same time, its valuation and risk profile are heavily influenced by medical-cost trends, regulatory pressure, and execution quality across both the insurance and services segments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
